ArticleEuropean journal of neurology2025
Defining True Motor Conduction Block in Chronic Immune-Mediated Demyelinating Neuropathies: A Temporal Dispersion-Based Electrodiagnostic Approach.
Article in European journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Conduction Block Detection in Dysimmune Neuropathy: Hypothetical Pathophysiological 'Truth' Versus Clinical Pragmatism.European journal of neurology · 2026Article
- Defining True Motor Conduction Block in Chronic Immune-Mediated Demyelinating Neuropathies: A Temporal Dispersion-Based Electrodiagnostic Approach.European journal of neurology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAbnormal temporal dispersion (TD) poses a significant challenge to the detection of motor conduction block (CB) in routine electrodiagnostic practice. However, the most recent electrodiagnostic criteria do not explicitly address the relationship between these phenomena. This study aimed to evaluate the impact of motor conduction velocity (MCV) slowing and abnormal TD on motor CB, and to establish TD-based electrodiagnostic criteria for the accurate identification of motor CB.
methodsElectrophysiological data from 35 patients diagnosed with chronic immune-mediated demyelinating neuropathies, according to the EAN/PNS electrodiagnostic criteria, were retrospectively analyzed. Linear regression models were employed to examine the relationship between MCV changes, TD, and proximal compound muscle action potential (p-CMAP) amplitude reduction.
resultsp-CMAP amplitude reduction was significantly associated with TD and MCV changes in the median, ulnar, and peroneal nerves (p < 0.001). Moreover, increases in TD accounted for 46.9% to 56.2% of the variability in p-CMAP amplitude reduction. In contrast, in the tibial nerve, TD explained only 21.8% of the observed variability. The regression analyses demonstrated that true motor CB could not be defined when abnormal TD exceeded 140% in the median nerve, 85% in the ulnar nerve, 185% in the peroneal nerve, and 240% in the tibial nerve. Furthermore, in the absence of abnormal TD, the cut-off values for detecting definite motor CB ranged from 40% to 60%, depending on the nerve examined.
conclusionsEven a marked decline in p-CMAP amplitude may not necessarily reflect true motor CB. Reliable determination of definite motor CB requires stringent, nerve-specific electrodiagnostic criteria that take abnormal TD into account.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.